 Proactive Investors Australia |
iSonea expands board expertise with new director appointments
Proactive Investors Australia iSonea recently reached an important milestone with the start of its first large US post-market study of its WheezoMeter™ monitoring device in paediatric patients with a range of asthma symptom severity. The study will include patients who are too … iSonea debuts asthma app platform |
View full post on asthma – Google News